Lymphocyte to C-reactive protein ratio as a novel inflammatory biomarker: Validation and clinical relevance as an independent prognostic factor in cholangiocarcinoma

Figure 1 Overall survival rates differ significantly between patients with cholangiocarcinoma who underwent radical resection, stratified by the lymphocyte-to-C-reactive protein ratio. LCR: Lymphocyte-to-C-reactive protein ratio; HR: Hazard ratio.

Figure 2 Multivariate Cox regression model for overall survival of cholangiocarcinoma patients. The black dots indicate the hazard ratio, and the horizontal line represents 95% confidence intervals. HR: Hazard ratio; CI: Confidence interval.

Figure 3 Comparison of receiver operating characteristic curves for the lymphocyte-to-C-reactive protein ratio, neutrophil-to-lymphocyte ratio, Glasgow Prognostic Score and C-reactive protein-albumin ratio in predicting overall survival. AUC: Area under the curve; LCR: Lymphocyte-to-C-reactive protein ratio; NLR: Neutrophil-to-lymphocyte ratio; CAR: C-reactive protein-albumin ratio; GPS: Glasgow Prognostic Score.